Essayer OR - Gratuit

Weight loss drug Mounjaro debuts, rivals in hot pursuit

Mint New Delhi

|

March 21, 2025

US company is pricing the anti-obesity treatment from ₹14,000 to ₹17,500 a month in India

- Jessica Jani

S drugmaker Eli Lilly & Co. brought its anti-obesity drug Mounjaro to India on Thursday, marking the country's first treatment of its kind, with monthly costs ranging from ₹14,000 to ₹17,500. The new drug, however, will face competition soon enough, with other foreign pharmaceutical companies planning to introduce similar products in a growing market.

Mounjaro's 2.5mg and 5mg vials will be priced at ₹3,500 and ₹4,375 respectively, in India. The injectable drug, used to treat obesity and type-2 diabetes, is to be taken once a week. The company had previously stated that it would price the drug, which costs around $1,000 per month ($86,315) in the US, competitively in India. "This India-specific pricing reflects Lilly's commitment to expanding access to innovative treatments in the country," the company said on Thursday.

PLUS D'HISTOIRES DE Mint New Delhi

Mint New Delhi

Stride raises $300-mn India, UK, GCC funds

Stride Ventures launched three funds across India, Gulf Cooperation Council and the UK, raising $300 million in the past six months to be deployed in respective territories, top executives at the venture debt platform said.

time to read

1 min

November 01, 2025

Mint New Delhi

Mint New Delhi

Berkshire’s new normal: No Buffett shareholder letter and no ‘Buffett premium’

Warren Buffett still has a couple months left as Berkshire Hathaway’s chief executive. The company’s shares are already feeling his absence.

time to read

4 mins

November 01, 2025

Mint New Delhi

Mint New Delhi

How the Mughals built their empire on conquest and contracts

This timely book reminds us that the fate of nations has always been written as much in account books as in battles

time to read

5 mins

November 01, 2025

Mint New Delhi

Mint New Delhi

Tata, JBM, others eye India’s biggest electric bus tender

Both officials spoke on the condition of anonymity asthe names of the potential bidders arenot public.

time to read

2 mins

November 01, 2025

Mint New Delhi

Mint New Delhi

Apple sets India revenue record on iPhone 17 surge

The company has now logged 14 consecutive quarters of record iPhone sales in the country

time to read

2 mins

November 01, 2025

Mint New Delhi

The modern traveller's flexiscape route

Travellers are ripping up rigid itineraries and picking destinations that offer it all: rest and adventure, cultural depth and effortless luxury

time to read

4 mins

November 01, 2025

Mint New Delhi

Benetton ex-CEO Sridharan to join as Puma India head

Ramprasad Sridharan, former managing director and chief executive of Benetton India, is set to take over as managing director of Puma India, said two people in the know. India is one of the German sportswear retailer's fastest growing markets where it faces rising competition.

time to read

2 mins

November 01, 2025

Mint New Delhi

Mint New Delhi

A fanged and toothed creature called hope

Megha Majumdar's second novel, set in a famine-stricken Kolkata of the near future, far surpasses her debut

time to read

3 mins

November 01, 2025

Mint New Delhi

Mint New Delhi

Collabs give desi sneakers a burst of speed

Homegrown shoe brands are dropping limited editions that draw on Indian pop culture

time to read

3 mins

November 01, 2025

Mint New Delhi

Mint New Delhi

Snapmint secures $125 million from new funding round

Consumer lending platform Snapmint has raised $125 million in a new funding round led by General Atlantic, with participation from Prudent Investment Managers, Kae Capital, Elev8 Venture Partners, and existing angel investors, the company said in a statement.

time to read

1 mins

November 01, 2025

Listen

Translate

Share

-
+

Change font size